Aviva’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Aviva’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-27,707	Closed	-$1.24M	–	998
2021 Q1	$1.24M	Buy	27,707 +3,491	+14%	+$163K	0.01%	783
2020 Q4	$1.38M	Sell	24,216 -19,631	-45%	-$1.16M	0.01%	799
2020 Q3	$2.25M	Buy	43,847 +4,827	+12%	+$236K	0.01%	728
2020 Q2	$2.33M	Buy	+39,020	New	+$2.09M	0.01%	648

Other funds holding DCPH

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Aviva's DCPH Position: Q2 2021 in Review

Aviva sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2021, closing a stake of 27,707 shares — an estimated $1.24M sold.

Aviva first reported a position in DCPH in Q2 2020 and held it in 4 quarters. The position peaked at $2.33M in Q2 2020. 147 funds tracked by Wall St. Rank hold DCPH as of Q2 2021.

Aviva reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Aviva sold 27,707 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $1.24M.
Aviva first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
Aviva's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2.33M in Q2 2020.
147 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Aviva's 13F filing for Q2 2021, filed 10 Aug 2021.